Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro

Leukemia and Lymphoma

Volumn 53, Issue 4, 2012, Pages 688-698

  Shu, Sherry T ^a   Dirksen, Wessel P ^b   Lanigan, Lisa G ^b   Martin, Chelsea K ^b   Thudi, Nanda K ^b,e   Werbeck, Jillian L ^c   Fernandez, Soledad A ^d   Hildreth, Blake E ^b   Rosol, Thomas J ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Department of Veterinary Biosciences ^*  (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e The University of Alabama at Birmingham   (United States)

Author keywords

Cell lines and animal models; Cytokine production and paraneoplastic conditions; Lymphocytes

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CD40 LIGAND; COLECALCIFEROL RECEPTOR; DEATH ASSOCIATED PROTEIN KINASE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PARATHYROID HORMONE RELATED PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STAT4 PROTEIN; TRANSCRIPTION FACTOR AP 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; SENSITIVITY ANALYSIS; T CELL LEUKEMIA; TUMOR GROWTH;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CD40 LIGAND; CELL LINE, TUMOR; CHEMOKINE CCL3; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INTERFERON-GAMMA; JURKAT CELLS; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, T-CELL; MALE; MICE; MICE, INBRED NOD; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARATHYROID HORMONE-RELATED PROTEIN; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT4 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859094084     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.626883     Document Type: Article

References (85)

1. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982;79:2031-2035.
2. Sagara Y, Inoue Y, Sagara Y, et al. Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia. Cancer Sci 2009;100:490-496.
3. Okada Y, Tsukada J, Nakano K, et al. Macrophage infl ammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia. J Bone Miner Res 2004;19:1105-1111.
4. Shu ST, Nadella MV, Dirksen WP, et al. A novel bioluminescent mouse model and eff ective therapy for adult T-cell leukemia/ lymphoma. Cancer Res 2007;67:11859-11866.
5. Anzai S, Takayasu S, Fujiwara S, et al. Elevation of IL-6 in ATL patient with a pathological fracture. J Dermatol 2002;29:644-647.
6. Nosaka K, Miyamoto T, Sakai T, et al. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood 2002;99: 634-640.
7. Richard V, Lairmore MD, Green PL, et al. Humoral hypercalcemia of malignancy: severe combined immunodefi cient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression. Am J Pathol 2001;158:2219-2228.
8. Takaori-Kondo A, Imada K, Yamamoto I, et al. Parathyroid hormone-related protein-induced hypercalcemia in SCID mice engrafted with adult T-cell leukemia cells. Blood 1998;91:4747-4751.
9. Harutsumi M, Akazai A, Kitamura T, et al. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein. Miner Electrolyte Metab 1995;21:171-176.
10. Yamaguchi K, Kiyokawa T, Watanabe T, et al. Increased serum levels of C-terminal parathyroid hormone-related protein in diff erent diseases associated with HTLV-1 infection. Leukemia 1994;8: 1708-1711.
11. Liao J, McCauley LK. Skeletal metastasis: established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev 2006;25:559-571.
12. Tsubaki M, Kato C, Manno M, et al. Macrophage infl ammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways. Mol Cell Biochem 2007;304:53-60.
13. Nadella MV, Shu ST, Dirksen WP, et al. Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation. Retrovirology 2008;5:46.
14. Martin TJ, Moseley JM, Williams ED. Parathyroid hormonerelated protein: hormone and cytokine. J Endocrinol 1997;154(Suppl.): S23-S37.
15. De Torres C, Beleta H, Diaz R, et al. Th e calcium-sensing receptor and parathyroid hormone-related protein are expressed in diff erentiated, favorable neuroblastic tumors. Cancer 2009;115: 2792-2803.
16. Massfelder T, Lang H, Schordan E, et al. Parathyroid hormonerelated protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res 2004;64:180-188.
17. Talon I, Lindner V, Sourbier C, et al. Antitumor eff ect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis 2006;27:73-83.
18. Choi SJ, Cruz JC, Craig F, et al. Macrophage infl ammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 2000;96:671-675.
19. Menu E, De Leenheer E, De Raeve H, et al. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clin Exp Metastasis 2006;23:291-300.
20. Terpos E, Politou M, Viniou N, et al. Signifi cance of macrophage infl ammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma 2005;46:1699-1707.
21. Richard V, Nadella MV, Green PL, et al. Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma. Leukemia 2005;19:1175-1183.
22. Han JH, Choi SJ, Kurihara N, et al. Macrophage infl ammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 2001;97:3349-3353.
23. Richard V, Luchin A, Brena RM, et al. Quantitative evaluation of alternative promoter usage and 3 ' splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR. Clin Chem 2003;49:1398-1402.
24. Holven KB, Damas JK, Yndestad A, et al. Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES. Arterioscler Th romb Vasc Biol 2006;26: 200-205.
25. Oyajobi BO, Franchin G, Williams PJ, et al. Dual eff ects of macrophage infl ammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Blood 2003;102:311-319.
26. Tannehill-Gregg SH, Levine AL, Nadella MV, et al. Th e eff ect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. Clin Exp Metastasis 2006;23:19-31.
27. Brady H, Desai S, Gayo-Fung LM, et al. Eff ects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models. Cancer Res 2002;62:1439-1442.
28. Nosaka K, Miyamoto T, Sakai T, et al. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood 2002;99: 634-640.
29. Richard V, Nadella MV, Green PL, et al. Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma. Leukemia 2005;19:1175-1183.
30. Shu ST, Martin CK, Th udi NK, et al. Osteolytic bone resorption in adult T-cell leukemia/lymphoma. Leuk Lymphoma 2010;51:702-714.
31. Ahuja SS, Zhao S, Bellido T, et al. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 2003;144:1761-1769.
32. Chattree V, Khanna N, Bisht V, et al. Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients. Mol Cell Biochem 2008;309:87-97.
33. Deiss LP, Feinstein E, Berissi H, et al. Identifi cation of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 1995;9:15-30.
34. Chuang YT, Fang LW, Lin-Feng MH, et al. Th e tumor suppressor death-associated protein kinase targets to TCR-stimulated NF-kappa B activation. J Immunol 2008;180:3238-3249.
35. Sytwu HK, Liblau RS, McDevitt HO. Th e roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996;5:17-30.
36. Schonbeck U, Libby P. Th e CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.
37. Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997;94:1931-1936.
38. Gauchat JF, Aubry JP, Mazzei G, et al. Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett 1993;315: 259-266.
39. Roy M, Waldschmidt T, Aruff o A, et al. Th e regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993;151:2497-2510.
40. Lee BO, Haynes L, Eaton SM, et al. Th e biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J Exp Med 2002;196:693-704.
41. Zou W, Hakim I, Tschoep K, et al. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast diff erentiation by an autocrine mechanism. J Cell Biochem 2001;83:70-83.
42. Kim HJ, Yoon MJ, Lee J, et al. Osteoprotegerin ligand induces betacasein gene expression through the transcription factor CCAAT/ enhancer-binding protein beta. J Biol Chem 2002;277:5339-5344.
43. Gade P, Roy SK, Li H, et al. Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol Cell Biol 2008;28:2528-2548.
44. Reichel H, Koeffl er HP, Tobler A, et al. 1α, 25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1987;84:3385-3389.
45. Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998;28:3017-3030.
46. Massfelder T, Dann P, Wu TL, et al. Opposing mitogenic and antimitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA 1997;94:13630-13605.
47. Henderson JE, Amizuka N, Warshawsky H, et al. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 1995;15:4064-4075.
48. Prager D, Rosenblatt JD, Ejima E. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leuk Lymphoma 1994;14:395-400.
49. Watanabe T, Yamaguchi K, Takatsuki K, et al. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J Exp Med 1990;172:759-765.
50. Cebrian A, Garcia-Ocana A, Takane KK, et al. Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro. Diabetes 2002;51:3003-3013.
51. Shen X, Mula RV, Evers BM, et al. Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines. Regul Pept 2007;141:61-72.
52. Ortega A, Ramila D, Izquierdo A, et al. Role of the reninangiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat. J Am Soc Nephrol 2005;16:939-949.
53. Ye Y, Falzon M, Seitz PK, et al. Overexpression of parathyroid hormone-related protein promotes cell growth in the rat intestinal cell line IEC-6. Regul Pept 2001;99:169-174.
54. Fiaschi-Taesch N, Sicari B, Ubriani K, et al. Mutant parathyroid hormone-related protein, devoid of the nuclear localization signal, markedly inhibits arterial smooth muscle cell cycle and neointima formation by coordinate up-regulation of p15Ink4b and p27kip1. Endocrinology 2009;150:1429-1439.
55. Falzon M, Du P. Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide. Endocrinology 2000;141:1882-1892.
56. Lentzsch S, Gries M, Janz M, et al. Macrophage infl ammatory protein 1-alpha (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 2003;101:3568-3573.
57. Choi SJ, Oba Y, Gazitt Y, et al. Antisense inhibition of macrophage infl ammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 2001;108:1833-1841.
58. Banchereau J, Bazan F, Blanchard D, et al. Th e CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
59. van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996;61:1-77.
60. Loke P, Allison JP. PD-L1 and PD-L2 are diff erentially regulated by Th 1 and Th 2 cells. Proc Natl Acad Sci USA 2003;100:5336-5341.
61. Olive D. [Lymphocyte coreceptors]. Med Sci (Paris) 2006;22: 1069-1074.
62. Liu Y, Janeway CA Jr. Interferon gamma plays a critical role in induced cell death of eff ector T cell: a possible third mechanism of selftolerance. J Exp Med 1990;172:1735-1749.
63. Dalton DK, Haynes L, Chu CQ, et al. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000;192:117-122.
64. Clerici M, Sarin A, Berzofsky JA, et al. Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and eff ected by lymphotoxin. AIDS 1996;10:603-611.
65. Alimonti JB, Ball TB, Fowke KR. Mechanisms of CD4+ T lymphocyte cell death in human immunodefi ciency virus infection and AIDS. J Gen Virol 2003;84:1649-1661.
66. Krishnan AV, Cramer SD, Bringhurst FR, et al. Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways. Endocrinology 1995;136:705-712.
67. Wong B, Choi Y. Pathways leading to cell death in T cells. Curr Opin Immunol 1997;9:358-364.
68. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003;66:1403-1408.
69. Th omas RJ, Guise TA, Yin JJ, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 1999;140:4451-4458.
70. Lang D, Mascarenhas JB, Powell SK, et al. PAX6 is expressed in pancreatic adenocarcinoma and is downregulated during induction of terminal diff erentiation. Mol Carcinog 2008;47:148-156.
71. Duparc RH, Abdouh M, David J, et al. Pax6 controls the proliferation rate of neuroepithelial progenitors from the mouse optic vesicle. Dev Biol 2007;301:374-387.
72. Ouyang J, Shen YC, Yeh LK, et al. Pax6 overexpression suppresses cell proliferation and retards the cell cycle in corneal epithelial cells. Invest Ophthalmol Vis Sci 2006;47:2397-2407.
73. Hoogendam J, Parlevliet E, Miclea R, et al. Novel early target genes of parathyroid hormone-related peptide in chondrocytes. Endocrinology 2006;147:3141-3152.
74. Kataoka TR, Nishizawa Y. Stat4 suppresses the proliferation of connective tissue-type mast cells. Lab Invest 2008;88:856-864.
75. Dalgin GS, Drever M, Williams T, et al. Identifi cation of novel epigenetic markers for clear cell renal cell carcinoma. J Urol 2008;180:1126-1130.
76. Orso F, Penna E, Cimino D, et al. AP-2alpha and AP-2gamma regulate tumor progression via specifi c genetic programs. FASEB J 2008;22:2702-2714.
77. Orso F, Fassetta M, Penna E, et al. Th e AP-2alpha transcription factor regulates tumor cell migration and apoptosis. Adv Exp Med Biol 2007;604:87-95.
78. Wajapeyee N, Somasundaram K. Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition. J Biol Chem 2003;278:52093-52101.
79. Chaudhary J, Johnson J, Kim G, et al. Hormonal regulation and diff erential actions of the helix-loop-helix transcriptional inhibitors of diff erentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology 2001;142:1727-1736.
80. Tam WF, Gu TL, Chen J, et al. Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells. Blood 2008;112:1981-1992.
81. Li J, Peet GW, Balzarano D, et al. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J Biol Chem 2001;276:18579-18590.
82. Kim H, Chung H, Kim HJ, et al. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 2008;112:287-296.
83. Fujita K, Tsujimura A, Hirai T, et al. Eff ect of human leukemia cells in testicular tissues grafted into immunodefi cient mice. Int J Urol 2008;15:733-738.
84. Pichiorri F, Trapasso F, Palumbo T, et al. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. Clin Cancer Res 2006;12:3494-3501.
85. Bertolini F, Fusetti L, Mancuso P, et al. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human highgrade non-Hodgkin lymphoma. Blood 2000;96:282-287.